ELISA – News and Features

Randox develops a multi marker Cardiac biochip array for rapid diagnosis of myocardial infarction and identification of at risk acute coronary syndrome patients.

Randox are working with the international racing laboratories to maintain the integrity of racing, to make certain animals are winning races on their own natural merits and to ensure the safety of the animals and jockeys is maintained.

Broad range of antibody products expands Thermo Fisher’s protein-research offering.

Phadia AB has implemented a series of HuCAL-based recombinant antibodies in its marketed autoimmune tests Varelisa™ and EliA™.

Immunalysis Corporation tailors the Tecan Freedom EVO 75 liquid handing workstation as the platform of choice to provide customized semi and fully automated drugs of abuse screening solutions.

Pronostics Ltd has signed a distribution agreement with Medipan GmbH, for its autoimmune disease biomarker assays.

Abcam plc. and Beckman Coulter, Inc. have announced a major bioscience collaboration – to create one of the world’s most sophisticated, automated systems for the production of monoclonal antibodies for use in research.

Dynex has designed the automated processing systems for clinical diagnostic assays & point-of-care test to screen children for lead poisoning.

MSI plans to produce biosensor products for research, diagnostic, biodefense and pharmacogenomic applications.

PerkinElmer to offer researchers a solution for assay development, optimization and conversion.